EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Calpain-Dependent Protein Degradation Contributes to CASQ2-R33Q CPVT

Laura Ramos-Hernández iD, Demetrio J Santiago, Rocío F Serrano-Blanco iD, Andrea Cancemi iD, Lorena Esteban-Martínez iD, Emilio Camafeita iD, Marina López-Olañeta, Deni Kukavica iD, Ana Guío-Carrión iD, Jesús M Vázquez iD, Miguel Torres iD, Silvia G Priori iD und 1 weitere

Circulation Research · 2026

DOI: 10.1161/circresaha.126.329035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation Research, 2026. Verfasst von Laura Ramos-Hernández und 12 weiteren Autor:innen. Beteiligte Einrichtung: Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain (L.R.-H., D.J.S., R.F.S.-B., A.C., L.E.-M., E.C., M.L.-O., A.G.-C., J.M.V.,…. Hauptthemen laut MEDLINE: Calsequestrin, Calpain, Tachycardia, Ventricular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmogenic disease associated with cardiac arrest in children and young adults. The recessive form of CPVT is caused by loss-of-function mutations in the genes encoding CASQ2 (calsequestrin 2) and TRDN (triadin), which, together with JCTN (junctin), regulate the release of calcium ions from the sarcoplasmic reticulum through the RyR2 (ryanodine receptor). The CASQ2 R33Q mutation causes calcium mishandling and ventricular tachycardia through triggered activity. The homozygous mouse model Casq2 R33Q/R33Q closely replicates the clinical phenotype of patients with CPVT. In this model, CASQ2, TRDN, and JCTN levels are markedly reduced; however, the mechanisms underlying this reduction and their contribution to CPVT are incompletely understood. METHODS: We used a combination of proteomics, animal models, and experimental methods to identify the molecular mechanisms responsible for the decrease of couplon proteins in Casq2 R33Q/R33Q mice and to explore their functional contribution to the disease. RESULTS: Casq2 R33Q/R33Q hearts showed activation of endoplasmic reticulum stress, the unfolded protein response, and alterations in major proteolytic pathways. Inhibition of the proteasome or autophagy in neonatal cardiomyocytes and adult mice partially restored CASQ2 but not TRDN levels, suggesting distinct degradation mechanisms. In contrast, calpain inhibition restored CASQ2 and TRDN protein levels, decreased triggered activity in isolated cardiomyocytes, and reduced ventricular tachycardia episodes in vivo in Casq2 R33Q/R33Q mice. Biochemical assays showed that TRDN is a direct calpain substrate. TRDN degradation preceded CASQ2 loss, and TRDN overexpression using modified RNA in cardiomyocytes or an adeno-associated viral vector in vivo increased CASQ2 levels in mutant mice, supporting an upstream role for TRDN destabilization. CONCLUSIONS: Couplon protein loss in CPVT associated with CASQ2-R33Q is mediated by coordinated but distinct proteolytic pathways, with calpain-dependent TRDN degradation representing a key pathogenic event that promotes CASQ2 destabilization and arrhythmogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CalsequestrinCalpainTachycardia, VentricularAnimalsPolymorphic Catecholaminergic Ventricular TachycardiaMyocytes, CardiacProteolysisMiceMuscle ProteinsCarrier ProteinsDisease Models, AnimalMutationAutophagyHumansUnfolded Protein ResponseCells, CulturedMice, TransgenicIntracellular Signaling Peptides and Proteins

Stichwörter der Autor:innen

autophagycalpainendoplasmic reticulum stressmyocytes, cardiactachycardia

Substanzen

CalsequestrinCalpaincasq2 protein, mouseMuscle ProteinsTrdn protein, mouseCarrier ProteinsIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain (L.R.-H., D.J.S., R.F.S.-B., A.C., L.E.-M., E.C., M.L.-O., A.G.-C., J.M.V., M.T., S.G.P., E.L.-P.).
  • Centro de Investigación Biomédica en Red Cardiovascular (CIBERCV), Madrid, Spain (E.C., J.M.V., M.T., E.L.-P.).
  • Department of Molecular Medicine, University of Pavia, Italy (D.K., S.G.P.).
  • Molecular Cardiology Unit, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy (D.K., S.G.P.).

ORCID-Profile: Laura Ramos-Hernández, Rocío F Serrano-Blanco, Andrea Cancemi, Lorena Esteban-Martínez, Emilio Camafeita, Deni Kukavica, Ana Guío-Carrión, Jesús M Vázquez, Miguel Torres, Silvia G Priori, Enrique Lara-Pezzi

Zitieren

APA

Ramos-Hernández, L., Santiago, D. J., Serrano-Blanco, R. F., Cancemi, A., Esteban-Martínez, L., Camafeita, E., López-Olañeta, M., Kukavica, D., Guío-Carrión, A., Vázquez, J. M., Torres, M., Priori, S. G., & Lara-Pezzi, E. (2026). Calpain-Dependent Protein Degradation Contributes to CASQ2-R33Q CPVT. Circulation Research. https://doi.org/10.1161/circresaha.126.329035

Vancouver

Ramos-Hernández L, Santiago DJ, Serrano-Blanco RF, Cancemi A, Esteban-Martínez L, Camafeita E, et al. Calpain-Dependent Protein Degradation Contributes to CASQ2-R33Q CPVT. Circulation Research. 2026. doi:10.1161/circresaha.126.329035

BibTeX
@article{RamosHernndez2026,
  author = {Ramos-Hernández, Laura and Santiago, Demetrio J and Serrano-Blanco, Rocío F and Cancemi, Andrea and Esteban-Martínez, Lorena and Camafeita, Emilio and López-Olañeta, Marina and Kukavica, Deni and Guío-Carrión, Ana and Vázquez, Jesús M and Torres, Miguel and Priori, Silvia G and Lara-Pezzi, Enrique},
  title = {Calpain-Dependent Protein Degradation Contributes to CASQ2-R33Q CPVT},
  journal = {Circulation Research},
  year = {2026},
  doi = {10.1161/circresaha.126.329035}
}
Kostenlos starten →